In TRPC6(−/−) mice, treatment with cilostazol had no additive effect on peripheral blood flow recovery after hindlimb ischaemia compared to vehicle treatment (Figure 6a,d), strongly suggesting the involvement of TRPC6 in anti‐peripheral arterial disease effect by cilostazol. Here, TRPC6 is linked to peripheral arterial disease.